UPDATE: Raymond James Downgrades Arcturus Therapeutics (ARCT) to Underperform
Tweet Send to a Friend
(Updated - August 12, 2021 7:40 AM EDT)
Raymond James analyst Steven Seedhouse downgraded Arcturus Therapeutics (NASDAQ: ARCT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Raymond James analyst Steven Seedhouse downgraded Arcturus Therapeutics (NASDAQ: ARCT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
